ArticleAdvances in therapy2021

Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts.

Xavier Forns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.